Published in Korean J Intern Med on March 01, 2002
Fundal dysaccommodation in functional dyspepsia: head-to-head comparison between the barostat and three-dimensional ultrasonographic technique. Gut (2006) 1.00
Novel targeted nuclear imaging agent for gastric cancer diagnosis: glucose-regulated protein 78 binding peptide-guided 111In-labeled polymeric micelles. Int J Nanomedicine (2013) 0.79
Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology (1998) 5.34
Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology (1998) 3.90
Gastric tone measured by an electronic barostat in health and postsurgical gastroparesis. Gastroenterology (1987) 2.10
Is there a role for gastric accommodation and satiety in asymptomatic obese people? Obes Res (2001) 1.84
Abnormal intragastric distribution of food during gastric emptying in functional dyspepsia patients. Gut (1994) 1.83
Development of a test to measure gastric accommodation in humans. Am J Physiol (1999) 1.56
Gastric mechanosensory and lower esophageal sphincter function in rumination syndrome. Am J Physiol (1998) 1.51
Impaired accommodation of proximal stomach to a meal in functional dyspepsia. Dig Dis Sci (1996) 1.47
Modulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humans. Gastroenterology (1999) 1.42
Responses to gastric distension in functional dyspepsia. Gut (1998) 1.32
Noninvasive measurement of gastric accommodation in patients with idiopathic nonulcer dyspepsia. Am J Gastroenterol (2001) 1.23
Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function. Gut (1999) 1.22
Subtraction ictal SPET co-registered to MRI in partial epilepsy: description and technical validation of the method with phantom and patient studies. Nucl Med Commun (1998) 1.20
Obesity: how big a problem? Science (1998) 1.19
The influence of cisapride on gastric tone and the perception of gastric distension. Aliment Pharmacol Ther (1998) 1.18
Gastric distension and gastric capacity in relation to food intake in humans. Physiol Behav (1988) 1.15
Visceral afferent neuropathy in diabetic gastroparesis. Diabetes Care (1991) 1.13
Role of nitric oxide in fasting gastric fundus tone and in 5-HT1 receptor-mediated relaxation of gastric fundus. Am J Physiol (1999) 1.11
Sumatriptan, a selective 5-HT1 receptor agonist, induces a lag phase for gastric emptying of liquids in humans. Am J Physiol (1997) 1.10
Intragastric distribution and gastric emptying assessed by three-dimensional ultrasonography. Gastroenterology (1997) 1.09
Gastric meal accommodation studied by ultrasound in diabetes. Relation to vagal tone. Scand J Gastroenterol (1998) 1.06
Proximal gastric motor activity in response to a liquid meal in type I diabetes mellitus with autonomic neuropathy. Dig Dis Sci (1998) 1.01
New software toolkits for comprehensive visualization and analysis of three-dimensional multimodal biomedical images. J Digit Imaging (1997) 1.00
Function of the proximal stomach after Nissen fundoplication. Br J Surg (1998) 0.97
Novel testing of human gastric motor and sensory functions: rationale, methods, and potential applications in clinical practice. Am J Gastroenterol (2000) 0.95
Relaxatory responses of canine proximal stomach to esophageal and duodenal distension. Importance of vagal pathways. Dig Dis Sci (1989) 0.89
Nuclear imaging of the stomach of healthy dogs. Am J Vet Res (1991) 0.88
Stomach distension in extremely obese and in normal subjects. Acta Chir Scand (1985) 0.87
Measurements of organ volume by ultrasonography. Proc Inst Mech Eng H (1999) 0.87
Reduced stomach capacity in obese subjects after dieting. Am J Clin Nutr (1996) 0.83
Pertechnetate and the Stomach--a continuing controversy. J Nucl Med (1983) 0.77
Usefulness of radionuclides in evaluation of stomach disorders. Semin Nucl Med (1972) 0.77
Functional gastroduodenal disorders. Gastroenterology (2006) 8.51
AGA technical review on irritable bowel syndrome. Gastroenterology (2002) 6.76
Chronic constipation. N Engl J Med (2003) 4.58
Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol (2007) 3.65
A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function. Gastroenterology (2013) 3.56
A randomized placebo-controlled phase IIb trial of a3309, a bile acid transporter inhibitor, for chronic idiopathic constipation. Am J Gastroenterol (2011) 2.81
Independent influences of body mass and gastric volumes on satiation in humans. Gastroenterology (2004) 2.63
Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia. Gastroenterology (2004) 2.48
Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome. Gastroenterology (2007) 2.30
A study of candidate genotypes associated with dyspepsia in a U.S. community. Am J Gastroenterol (2006) 2.30
Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea. Clin Gastroenterol Hepatol (2012) 2.13
Symptomatic overlap between irritable bowel syndrome and microscopic colitis. Inflamm Bowel Dis (2007) 1.97
Contribution of endogenous glucagon-like peptide 1 to glucose metabolism after Roux-en-Y gastric bypass. Diabetes (2013) 1.90
Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. J Nucl Med Technol (2008) 1.90
Drawing a blank in functional dyspepsia? Gastroenterology (2006) 1.89
Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function. Clin Gastroenterol Hepatol (2009) 1.87
Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol (2003) 1.86
Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study. Am J Gastroenterol (2004) 1.86
Rumination syndrome in children and adolescents: diagnosis, treatment, and prognosis. Pediatrics (2003) 1.76
A community-based, controlled study of the epidemiology and pathophysiology of dyspepsia. Clin Gastroenterol Hepatol (2004) 1.75
A system model of oral glucose absorption: validation on gold standard data. IEEE Trans Biomed Eng (2006) 1.66
Gastric accommodation and emptying in evaluation of patients with upper gastrointestinal symptoms. Clin Gastroenterol Hepatol (2003) 1.66
Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans. Am J Physiol Gastrointest Liver Physiol (2002) 1.58
Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis. Gastroenterology (2010) 1.53
Effect of alginate on satiation, appetite, gastric function, and selected gut satiety hormones in overweight and obesity. Obesity (Silver Spring) (2009) 1.52
Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials. Clin Gastroenterol Hepatol (2008) 1.52
Effects of dipeptidyl peptidase-4 inhibition on gastrointestinal function, meal appearance, and glucose metabolism in type 2 diabetes. Diabetes (2007) 1.47
Linaclotide, a synthetic guanylate cyclase C agonist, for the treatment of functional gastrointestinal disorders associated with constipation. Expert Rev Gastroenterol Hepatol (2011) 1.47
Gastric sensory and motor dysfunction in adolescents with functional dyspepsia. J Pediatr (2005) 1.46
Developing irritable bowel syndrome guidelines through meta-analyses: does the emperor really have new clothes? Gastroenterology (2009) 1.43
A nutrient drink test to assess maximum tolerated volume and postprandial symptoms: effects of gender, body mass index and age in health. Neurogastroenterol Motil (2002) 1.39
Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome. Clin Gastroenterol Hepatol (2008) 1.39
Gastric sensorimotor functions and hormone profile in normal weight, overweight, and obese people. Gastroenterology (2006) 1.39
Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls. Am J Physiol Gastrointest Liver Physiol (2011) 1.38
The HIPAA authorization form and effects on survey response rates, nonresponse bias, and data quality: a randomized community study. Med Care (2007) 1.37
Relationship between clinical features and gastric emptying disturbances in diabetes mellitus. Clin Endocrinol (Oxf) (2008) 1.37
Is there an association between GNbeta3-C825T genotype and lower functional gastrointestinal disorders? Gastroenterology (2006) 1.35
Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation. Am J Gastroenterol (2011) 1.33
Effect of daikenchuto (TU-100) on gastrointestinal and colonic transit in humans. Am J Physiol Gastrointest Liver Physiol (2010) 1.32
Determination of gastric emptying in nonobese diabetic mice. Am J Physiol Gastrointest Liver Physiol (2007) 1.28
Dietary fiber supplements: effects in obesity and metabolic syndrome and relationship to gastrointestinal functions. Gastroenterology (2009) 1.27
Do corticotropin releasing factor-1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome? Am J Physiol Gastrointest Liver Physiol (2009) 1.24
A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice. J Clin Invest (2004) 1.23
High body mass alters colonic sensory-motor function and transit in humans. Am J Physiol Gastrointest Liver Physiol (2008) 1.22
A Klothoβ variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea. Gastroenterology (2011) 1.22
Dipeptidyl peptidase-4 inhibition by vildagliptin and the effect on insulin secretion and action in response to meal ingestion in type 2 diabetes. Diabetes Care (2008) 1.20
Phenotypic variation of colonic motor functions in chronic constipation. Gastroenterology (2009) 1.20
Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol (2013) 1.20
Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health. Am J Physiol Gastrointest Liver Physiol (2003) 1.17
Gastroparesis: clinical update. Am J Gastroenterol (2006) 1.15
Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study. Am J Physiol Gastrointest Liver Physiol (2007) 1.14
Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans. Am J Physiol Gastrointest Liver Physiol (2003) 1.13
Methods for diagnosis of bile acid malabsorption in clinical practice. Clin Gastroenterol Hepatol (2013) 1.12
Psychometric evaluation of patient-reported outcomes in irritable bowel syndrome randomized controlled trials: a Rome Foundation report. Gastroenterology (2009) 1.11
Effect of CCK-1 antagonist, dexloxiglumide, in female patients with irritable bowel syndrome: a pharmacodynamic and pharmacogenomic study. Am J Gastroenterol (2005) 1.09
Effect of a chloride channel activator, lubiprostone, on colonic sensory and motor functions in healthy subjects. Am J Physiol Gastrointest Liver Physiol (2008) 1.09
Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans. Clin Gastroenterol Hepatol (2003) 1.08
Cannabinoids in intestinal inflammation and cancer. Pharmacol Res (2009) 1.08
Effect of alvimopan and codeine on gastrointestinal transit: a randomized controlled study. Clin Gastroenterol Hepatol (2005) 1.08
The gastrointestinal tract and glucose tolerance. Curr Opin Clin Nutr Metab Care (2004) 1.07
Effect of gastric volume or emptying on meal-related symptoms after liquid nutrients in obesity: a pharmacologic study. Clin Gastroenterol Hepatol (2005) 1.07
A stable isotope breath test with a standard meal for abnormal gastric emptying of solids in the clinic and in research. Clin Gastroenterol Hepatol (2008) 1.05
Efficacy of on-demand asimadoline, a peripheral kappa-opioid agonist, in females with irritable bowel syndrome. Clin Gastroenterol Hepatol (2007) 1.04
Regional colon transit in patients with dys-synergic defaecation or slow transit in patients with constipation. Gut (2011) 1.04
Gastric motor and sensory functions in obesity. Obes Res (2005) 1.04
Methods for measurement of gastric motility. Am J Physiol Gastrointest Liver Physiol (2009) 1.03
A controlled pharmacogenetic trial of sibutramine on weight loss and body composition in obese or overweight adults. Gastroenterology (2008) 1.03
Randomized controlled phase Ib study of ghrelin agonist, RM-131, in type 2 diabetic women with delayed gastric emptying: pharmacokinetics and pharmacodynamics. Diabetes Care (2012) 1.02
A concerted decline in insulin secretion and action occurs across the spectrum of fasting and postchallenge glucose concentrations. Clin Endocrinol (Oxf) (2012) 1.02
Defects in GLP-1 response to an oral challenge do not play a significant role in the pathogenesis of prediabetes. J Clin Endocrinol Metab (2011) 1.01
Irritable bowel syndrome: recent and novel therapeutic approaches. Drugs (2006) 1.01
Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans. Am J Physiol Regul Integr Comp Physiol (2008) 1.00
Association of HLA-DQ gene with bowel transit, barrier function, and inflammation in irritable bowel syndrome with diarrhea. Am J Physiol Gastrointest Liver Physiol (2012) 0.99
Recent advances in clinical practice challenges and opportunities in the management of obesity. Gut (2014) 0.98
Effect of oral CCK-1 agonist GI181771X on fasting and postprandial gastric functions in healthy volunteers. Am J Physiol Gastrointest Liver Physiol (2004) 0.97
Visceral hypersensitivity. J Clin Gastroenterol (2005) 0.96
A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation. Gut (2012) 0.94
Pilot study of pyridostigmine in constipated patients with autonomic neuropathy. Clin Auton Res (2008) 0.94
Paraneoplastic autoimmune multiorgan syndrome: 20 years after. Int J Dermatol (2011) 0.94
Recommendations for probiotic use. J Clin Gastroenterol (2006) 0.94
Common genetic variation in GLP1R and insulin secretion in response to exogenous GLP-1 in nondiabetic subjects: a pilot study. Diabetes Care (2010) 0.94
Pharmacogenetic trial of a cannabinoid agonist shows reduced fasting colonic motility in patients with nonconstipated irritable bowel syndrome. Gastroenterology (2011) 0.94
Feasibility and application of 3-dimensional ultrasound for measurement of gastric volumes in healthy adults and adolescents. J Pediatr Gastroenterol Nutr (2009) 0.93
New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders. Expert Opin Investig Drugs (2010) 0.93
Obesity does not increase effects of synthetic ghrelin on human gastric motor functions. Gastroenterology (2006) 0.93
Definitions and outcome measures of clinical trials regarding opioid-induced constipation: a systematic review. J Clin Gastroenterol (2015) 0.92
Effects of amitriptyline on gastric sensorimotor function and postprandial symptoms in healthy individuals: a randomized, double-blind, placebo-controlled trial. Am J Gastroenterol (2008) 0.92
Dose-response effect of a beta3-adrenergic receptor agonist, solabegron, on gastrointestinal transit, bowel function, and somatostatin levels in health. Am J Physiol Gastrointest Liver Physiol (2008) 0.92
Alteration of gastric functions and candidate genes associated with weight reduction in response to sibutramine. Clin Gastroenterol Hepatol (2007) 0.92
Pseudo-obstruction in the critically ill. Best Pract Res Clin Gastroenterol (2003) 0.91
Effect of different macronutrients in excess on gastric sensory and motor functions and appetite in normal-weight, overweight, and obese humans. Am J Clin Nutr (2007) 0.91
The role of peptide YY in integrative gut physiology and potential role in obesity. Curr Opin Endocrinol Diabetes Obes (2007) 0.91
The ghrelin agonist RM-131 accelerates gastric emptying of solids and reduces symptoms in patients with type 1 diabetes mellitus. Clin Gastroenterol Hepatol (2013) 0.91
Methods for the assessment of small-bowel and colonic transit. Semin Nucl Med (2012) 0.91
Functional dyspepsia, upper gastrointestinal symptoms, and transit in children. J Pediatr (2003) 0.90
Pharmacogenetics of the effects of colesevelam on colonic transit in irritable bowel syndrome with diarrhea. Dig Dis Sci (2012) 0.90
Gender differences in irritable bowel syndrome. J Gend Specif Med (2002) 0.90
Relationship of gastric emptying and volume changes after a solid meal in humans. Am J Physiol Gastrointest Liver Physiol (2005) 0.90
The effect of dipeptidyl peptidase-4 inhibition on gastric volume, satiation and enteroendocrine secretion in type 2 diabetes: a double-blind, placebo-controlled crossover study. Clin Endocrinol (Oxf) (2008) 0.90
The role of pelvic floor dysfunction and slow colonic transit in adolescents with refractory constipation. Am J Gastroenterol (2004) 0.90